Related Experiment Video

Updated: Aug 16, 2026

Semi-Quantitative Analysis of Peptidoglycan by Liquid Chromatography Mass Spectrometry and Bioinformatics
09:09

Semi-Quantitative Analysis of Peptidoglycan by Liquid Chromatography Mass Spectrometry and Bioinformatics

Published on: October 13, 2020

Peptidoglycan precursor pools associated with MraY and FtsW deficiencies or antibiotic treatments

Beatriz Lara1, Dominique Mengin-Lecreulx, Juan A Ayala

  • 1Enveloppes Bactériennes et Antibiotiques, UMR 8619 CNRS, Bâtiment 430, Université Paris-Sud, 91405 Orsay, France.

FEMS Microbiology Letters
|August 16, 2005
PubMed

Insights

Blocking peptidoglycan synthesis in Escherichia coli using moenomycin or vancomycin increases UDP-MurNAc-pentapeptide levels. Other inhibitors like penicillin G decrease these levels, revealing distinct mechanisms in bacterial cell wall synthesis.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Peptidoglycan is essential for bacterial cell wall integrity.
  • Understanding the synthesis pathway is crucial for developing new antibiotics.
  • Escherichia coli is a model organism for studying bacterial processes.

Purpose of the Study:

  • To investigate the effects of different peptidoglycan synthesis inhibitors on nucleotide precursor pools in Escherichia coli.
  • To elucidate the specific mechanisms by which various inhibitors impact UDP-MurNAc-pentapeptide levels.

Main Methods:

  • Treatment of Escherichia coli with moenomycin, vancomycin, cephaloridine, or penicillin G.
  • Analysis of intracellular nucleotide precursor pools, specifically UDP-MurNAc-pentapeptide and its precursors.
  • Investigation of strains deficient in MraY and FtsW proteins involved in peptidoglycan synthesis.

Main Results:

  • Moenomycin and vancomycin treatments resulted in the accumulation of UDP-MurNAc-pentapeptide and its upstream precursors.
  • Cephaloridine and penicillin G treatments led to a decrease in UDP-MurNAc-pentapeptide levels.
  • MraY and FtsW deficiencies caused a decrease in UDP-MurNAc-pentapeptide, an increase in upstream precursors, and the formation of UDP-MurNAc-tetrapeptide.

Conclusions:

  • Different classes of peptidoglycan synthesis inhibitors exert distinct effects on the nucleotide precursor pools.
  • These findings provide insights into the regulation of peptidoglycan synthesis and potential targets for novel antibacterial agents.
  • The study highlights the complex interplay of enzymes and substrates in maintaining bacterial cell wall homeostasis.

More Related Videos

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis09:26

Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis

Published on: May 23, 2021

Related Concept Videos

Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...